Effect of DORA-22 on Memory, Sleep, and Brain Amyloid-beta Levels in 5XFAD Mice, a Model for Alzheimer's Disease

Grants and Contracts Details

StatusFinished
Effective start/end date11/2/1611/2/18

Funding

  • Merck and Company Inc: $165,004.00